RSS-Feed abonnieren
DOI: 10.1055/s-0030-1269847
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
Direct Costs of Diabetes Mellitus in Germany – CoDiM 2000–2007
Publikationsverlauf
received 27.09.2010
first decision 27.09.2010
accepted 17.11.2010
Publikationsdatum:
24. Januar 2011 (online)

Abstract
Introduction: The prevalence of treated diabetes in Germany and direct health care costs of individuals with diabetes were analysed for the 8-year period from 2000 to 2007, based on administrative data. Special interest was given to the incremental costs attributed to diabetes.
Material and methods: An 18.75% sample of all members of a large local German statutory health insurance provider, “AOK – Die Gesundheitskasse” in the federal state of Hesse was analysed with regard to cases of treated diabetes. To assess the incremental diabetes-related direct costs, the cost data of individuals with diabetes was compared to that of an age- and sex-matched group of persons without diabetes. Prevalence and costs were standardized according to the gender and age distribution of the German population.
Results: Between 2000 and 2007, the administrative prevalence of treated diabetes rose continuously in Germany, from 6.5 to 8.9% (+36.8%). The number of patients treated with ‘insulin’ or ‘insulin & oral antidiabetic agents’ increased by +54.7 and +61.7%, respectively. Direct costs per patient with diabetes, calculated using the unit costs reimbursed by statutory health and nursing care insurances, rose from € 5 197 to € 5 726 (+10.2%). Incremental per-capita costs were € 2 400 in 2000 and € 2 605 in 2007 (+8.5%). However, the total direct cost burden of diabetes in Germany grew from € 27.8 billion to € 42.0 billion (+51.1%). The incremental diabetes-related cost burden increased from € 12.9 billion to € 19.1 billion (+48.6%).
Conclusions: There was a continuous increase in the prevalence of diabetes in Germany during the 8-year period. Although there was only a modest increase in annual diabetes-related per-capita costs, total healthcare expenditure rose substantially due to the growing number of patients being treated for diabetes.
Key words
diabetes mellitus - diabetes-related costs - healthcare costs - claims data - antidiabetic agents
References
- 1 Albrecht M, de Millas C, Hildebrandt S. et al .Die Bedeutung von Wettbewerb im Bereich der privaten Krankenversicherungen vor dem
Hintergrund der erwarteten demografischen Entwicklung. Forschungsprojekt des Bundesministeriums
für Wirtschaft und Technologie. Schlussbericht IGES Institut GmbH, Berlin; 2010: 91-99
MissingFormLabel
- 2
American Diabetes Association
.
Economic costs of diabetes in the US in 2002.
Diabetes Care.
2003;
26
917-932
MissingFormLabel
- 3
American Diabetes Association
.
Economic Costs of Diabetes in the US in 2007.
Diabetes Care.
2008;
31
596-615
MissingFormLabel
- 4
Brandle M, Zhou H, Smith BRK. et al .
The direct medical cost of type 2 diabetes.
Diabetes Care.
2003;
26
2300-2304
MissingFormLabel
- 5
BMG – Bundesministerium für Gesundheit Berlin
.
Gesetzliche Krankenversicherung – Kennzahlen und Faustformeln – Status: 4 March 2009.
Available from
http://www.bmg.bund.de
Assessed 28 January
2010;
MissingFormLabel
- 6
DESTATIS – Statistisches Bundesamt Wiesbaden
.
Gesundheit-Ausgaben, Krankheitskosten und Personal-Methodik.
Available from
http://www.gbe-bund.de/gbe10/ergebnisse.prc.achkz=D&p_uid=gasts&p_ aid=44013136&p_prot=1
Assessed 12 August
2010a;
MissingFormLabel
- 7
DESTATIS – Statistisches Bundesamt Wiesbaden
.
Gesundheit-Krankheitskosten 2002, 2004 und 2006.
Statistisches Bundesamt Wiesbaden
2008;
MissingFormLabel
- 8
DESTATIS – Statistisches Bundesamt Wiesbaden
.
Gesundheitsberichterstattung des Bundes.
Available from
http://www.gbe-bund.de
Rahmenbedingungen>Gesetzliche Krankenversicherung>GKV, Mitglieder/Versicherte Assessed
6 August
2010b;
MissingFormLabel
- 9
Engelgau MM, Geiss LS, Saaddine JB. et al .
The evolving diabetes burden in the United States.
Ann Intern Med.
2004;
140
945-950
MissingFormLabel
- 10
Ettaro L, Songer TJ, Zhang P. et al .
Cost-of-illness studies in diabetes mellitus.
Pharmacoecon.
2004;
22
149-164
MissingFormLabel
- 11 Giani G, Janka HU, Hauner H. et al .Epidemiologie und Verlauf des Diabetes mellitus in Deutschland. In: Scherbaum WA, Kiess W (eds) Evidenzbasierte Leitlinie Deutsche Diabetes Gesellschaft
– Update May Available from http://www.deutsche-diabetes-gesellschaft.de/redaktion/mitteilungen/leitlinien/EBL_Epidemiologie_Update_2004.pdf Assessed 13 August 2010 2004
MissingFormLabel
- 12
Hauner H, Köster I, von Ferber L.
Prevalence of diabetes mellitus in Germany 1998–2001. Sekundärdaten einer Versichertenstichprobe
der AOK Hessen/KV Hessen.
DMW.
2003;
128
2632-2637
MissingFormLabel
- 13
Hauner H, Köster I, Schubert I.
Trends in der Prävalenz und ambulanten Versorgung von Menschen mit Diabetes mellitus.
Eine Analyse der Versichertenstichprobe AOK Hessen/KV Hessen im Zeitraum von 1998
bis 2004.
Dtsch Arztebl.
2007;
104
(41)
A805-A2799
MissingFormLabel
- 14
Henriksson F, Agardh CD, Berne C. et al .
Health economics analysis of diabetes is necessary. It facilitates decision-making
and international comparison. Health economics analysis of diabetes is necessary.
Lakartidningen.
1999;
96
3915-3916
3919
MissingFormLabel
- 15
Ihle P, Köster I, Herholz H. et al .
Versichertenstichprobe AOK Hessen/KV Hessen – Konzeption und Umsetzung einer personenbezogenen
Datenbasis aus der Gesetzliche Krankenversicherung.
Gesundheitswesen.
2005;
67
638-645
MissingFormLabel
- 16
International Diabetes Foundation (IDF) Diabetes Atlas 2010
.
Available from
http://www.diabetesatlas.org/downloads
Assessed 6 August
2010;
MissingFormLabel
- 17
Jönsson B.
Revealing the cost of Type II diabetes in Europe.
Diabetologia.
2002;
45
S5-S12
MissingFormLabel
- 18
Köster I, von Ferber L, Ihle P. et al .
The cost burden of diabetes mellitus: the evidence from Germany – the CoDiM Study.
Diabetologia.
2006;
49
1498-1504
MissingFormLabel
- 19
Liebl A, Spannheimer A, Reitberger U. et al .
Kosten für Spätkomplikationen bei Diabetes mellitus Typ 2 in Deutschland. Ergebnisse
der CODE-2 Studie.
Med Klin.
2002;
97
713-719
MissingFormLabel
- 20 Noethen M. Men and women in the public health system: A comparison of costs. STATmagazin; Federal Statistical Office, Wiesbaden, Germany; 2009. 3 February 2009. Available from http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/Internet/EN/Content/Publikationen/STATmagazin/Health/2009__02/PDF2009__02.psml Assessed 6 August 2010
MissingFormLabel
- 21
Pohar SL, Johnson JA.
Health care utilization and costs in Saskatchewan's registered Indian population with
diabetes.
BMC Health Serv Res.
2007;
7
126
MissingFormLabel
- 22
Selby JV, Ray GT, Zhang D. et al .
Excess costs of medical care for patients with diabetes in a managed care population.
Diabetes Care.
1997;
20
1396-1402
MissingFormLabel
- 23
Stock SAK, Redaelli M, Wendland G. et al .
Diabetes – prevalence and cost of illness in Germany: a study evaluating data from
the statutory health insurance in Germany.
Diabet Med.
2006;
23
299-305
MissingFormLabel
- 24
von Ferber L, Köster I, Hauner H.
Costs of the treatment of hyperglycaemia in patients with diabetes mellitus. The impact
of age, type of therapy and complications: Results of the German CoDiM study.
Med Klin.
2006;
101
384-393
MissingFormLabel
- 25
von Ferber L, Köster I, Hauner H.
Medical Costs of Diabetic Complications – Total Costs and Excess Costs by Age and
Type of Treatment: Results of the German CoDiM Study.
Exp Clin Endocrinol Diabetes.
2007;
115
97-104
MissingFormLabel
Correspondence
I. Köster
PMV forschungsgruppe an
der Klinik und Poliklinik für
Psychiatrie und Psychotherapie
des Kindes- und Jugendalters,
Klinikum Köln
Herderstr. 52– 54
50931 Köln
Germany
Telefon: +49/221/478 6545
Fax: +49/221/478 6766
eMail: ingrid.koester@uk-koeln.de